Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Louis

Showing results (631-640 of 653) with videos related to

Pageof 66
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 studyFleur M Louis, Anna van der Voort, Mees D Egeler, et al.
American Journal of Perinatology|October 26, 2019
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind TrialSean C Blackwell, Cynthia Gyamfi-Bannerman, Joseph R Biggio, et al.
European Journal of Cardiovascular Nursing|April 8, 2026
The Impact of a Gamified Engagement Toolkit on Heart Failure Registry Participation: Results of the Engage-HF StudyAbdul Shakoor, Niels Scholte, Rik van de Kamp, et al.
American Journal of Obstetrics and Gynecology|June 2, 2024
Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testingJimmy Espinoza, Vinicius F Calsavara, Sarah Kilpatrick, et al.
American Journal of Obstetrics and Gynecology|March 10, 2015
NuMoM2b Sleep-Disordered Breathing study: objectives and methodsFrancesca L Facco, Corette B Parker, Uma M Reddy, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic HealthFrancesca L Facco, Susan Redline, Shannon M Hunter, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|May 2, 2023
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021Kathryn Miele, Shin Y Kim, Rachelle Jones, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
The Lancet. Oncology|February 19, 2026
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 studyFleur M Louis, Anna van der Voort, Mette S van Ramshorst, et al.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Pageof 66

Showing results (631-640 of 653) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 studyFleur M Louis, Anna van der Voort, Mees D Egeler, et al.
American Journal of Perinatology|October 26, 2019
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind TrialSean C Blackwell, Cynthia Gyamfi-Bannerman, Joseph R Biggio, et al.
European Journal of Cardiovascular Nursing|April 8, 2026
The Impact of a Gamified Engagement Toolkit on Heart Failure Registry Participation: Results of the Engage-HF StudyAbdul Shakoor, Niels Scholte, Rik van de Kamp, et al.
American Journal of Obstetrics and Gynecology|June 2, 2024
Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testingJimmy Espinoza, Vinicius F Calsavara, Sarah Kilpatrick, et al.
American Journal of Obstetrics and Gynecology|March 10, 2015
NuMoM2b Sleep-Disordered Breathing study: objectives and methodsFrancesca L Facco, Corette B Parker, Uma M Reddy, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic HealthFrancesca L Facco, Susan Redline, Shannon M Hunter, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|May 2, 2023
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021Kathryn Miele, Shin Y Kim, Rachelle Jones, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
The Lancet. Oncology|February 19, 2026
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 studyFleur M Louis, Anna van der Voort, Mette S van Ramshorst, et al.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Pageof 66